Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: A retrospective study on the impact of HIV infection and its treatment

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 312-319

  Bateganya, Moses H ^a   Stanaway, Jeffrey ^a   Brentlinger, Paula E ^a   Magaret, Amalia S ^a   Wald, Anna ^a   Orem, Jackson ^b   Casper, Corey ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UGANDA CANCER INSTITUTE   (Uganda)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

antiretroviral therapy; HIV; non Hodgkin lymphoma; Uganda

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UGANDA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UGANDA; YOUNG ADULT;

EID: 79952369825     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820c011a     Document Type: Article

References (45)

1. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148:728-736. (Pubitemid 351717418)
2. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123:187-194. (Pubitemid 351705208)
3. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67. (Pubitemid 47017468)
4. Stein L, Urban MI, O'Connell D, et al. The spectrum of human immunodeficiency virus associated cancers in a South African black population: results from a case control study, 1995-2004. Int J Cancer. 2008;122:2260-2265. (Pubitemid 351542329)
5. Mwakigonja AR, Kaaya EE, Mgaya EM. Malignant lymphomas (ML) and HIV infection in Tanzania. J Exp Clin Cancer Res. 2008;27:9.
6. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: The EuroSIDA study. Lancet. 2000;356:291-296. (Pubitemid 30459587)
7. Wabinga HR, Parkin DM, Wabwire-Mangen F, et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer. 2000; 82:1585-1592. (Pubitemid 30204367)
8. Parkin DM, Wabinga H, Nambooze S, et al. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS. 1999;13: 2563-2570. (Pubitemid 30038035)
9. Gondos A, Brenner H, Wabinga H, et al. Cancer survival in Kampala, Uganda. Br J Cancer. 2005;92:1808-1812. (Pubitemid 40756498)
10. Parkin DM, Ferlay J, Hamdi-Cherif M, et al, eds. Cancer in Africa: Epidemiology and Prevention. Lyon, France: IARC, 2003. No.
11. Parkin DM, Garcia-Giannoli H, Raphael M, et al. Non-Hodgkin's lymphoma in Uganda: A case control study. AIDS. 2000;14:2929-2936.
12. The International NHL Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
13. Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109:1857-1861. (Pubitemid 46348180)
14. Tumwine LK, Agostinelli C, Campidelli C, et al. Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. BMC Clin Pathol. 2009;9:11.
15. Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs. 2003;63:803-843. (Pubitemid 36432084)
16. Pettengell R, Gurney H, Radford J, et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood. 1992;80:1430-1436.
17. Remick SC, Sedransk N, Haase RF, et al. Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up. Am J Hematol. 2001;66:178-188. (Pubitemid 32167455)
18. Vaccher E, Tirelli U, Spina M, et al. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients. J Clin Oncol. 1996;14:2217-2223. (Pubitemid 26264871)
19. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 Patients (1981-1986). Ann Intern Med. 1988;108:744-753.
20. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
21. Levine AM. Acquired immunodeficiency syndrome-related lymphomas: clinical aspects. Semin Oncol. 2000;27:442-453. (Pubitemid 30626443)
22. Diamond C, Taylor TH, Im T, et al. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol. 2006;24: 139-145. (Pubitemid 44483907)
23. Diamond C, Taylor TH, Anton-Culver H. Quality of life, characteristics and survival of patients with HIVand lymphoma. Qual Life Res. 2010;19: 149-155.
24. Biggar RJ, Engels EA, Ly S, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr. 2005;39:293-299. (Pubitemid 40923208)
25. Bohlius J, Schmidlin K, Costagliola D, et al. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS. 2009;23:2029-2037.
26. Bower M, Gazzard B, Mandalia S, et al. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med. 2005;143:265-273.
27. Diamond C, Taylor TH, Im T, et al. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma. 2006;47: 1822-1829. (Pubitemid 44649767)
28. Smeland S, Blystad AK, Kvaløy SO, et al. Treatment of Burkitt's/Burkittlike lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol. 2004;15:1072-1078. (Pubitemid 39089784)
29. Lim ST, Karim R, Nathwani BN, et al. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: Significant differences in survival with standard chemotherapy. J Clin Oncol. 2005;23:4430-4438. (Pubitemid 46207018)
30. Orem J, Maganda A, Katongole ME, et al. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer. 2009;52:455-458.
31. Savage L. Former African cancer research powerhouse makes plans for a return to greatness. J Natl Cancer Inst. 2007;99:1144-1151.
32. Uganda Ministry of Health. Routine HIV Counseling and Testing Manual. Kampala, Uganda: Ministry of Health-ACP, 2006.
33. National Cancer Institute sponsored study of classifications of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer. 1982;49:2112-2135.
34. Pileri SA, Milani M, Fraternali-Orcioni G, et al. From the R.E.A.L. Classification to the upcoming WHO scheme: A step toward universal categorization of lymphoma entities? Ann Oncol. 1998;9:607.
35. World Health Organization, Gilks C, Vitó ria M. Antiretroviral therapy for HIV infection in adults and adolescents recommendations for a public health approach. Available at: http://www.who.int/hiv/pub/ guidelines/ artadultguidelines.pdf. Accessed August 12, 2008.
36. Coiffier B, Lepage E, Brière J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-242. (Pubitemid 34438862)
37. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumors in developed and developing countries. Eur J Cancer. 2001;37: 1188-1201. (Pubitemid 32553764)
38. Nguyen HQ, Okuku F, Sewankambo F, et al. AIDS-Associated Kaposi sarcoma in Uganda: response to treatment with antiretroviral therapy and chemotherapy. Infect Agent Cancer. 2009;4(Suppl 2):05539.
39. Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer. 2006;106:128-135. (Pubitemid 43032557)
40. Robotin M, Law M, Milliken S, et al. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. HIV Med. 2004;5:377-384. (Pubitemid 39276337)
41. Lim ST, Karim R, Tulpule A, et al. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol. 2005;23:8477-8482.
42. Uganda Ministry of Health. Routine HIV Counselling and Testing Manual. Kampala, Uganda: Ministry of Health-ACP, 2006.
43. UNAIDS. Report on the Global AIDS Epidemic. 2008; Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ 2008-Global-report.asp. Accessed March 15, 2009.
44. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Convention. Geneva, Switzerland: World Health Organization; 1999.
45. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res. 1998;6(Suppl 2):S51-S209.